The Global Cardio-Oncology Summit (GCOS) 2026 took place from October 5–7, 2026, at the Williamsburg Lodge in Williamsburg, Virginia, USA.
Held under the theme “Cardio-Oncology Innovation and Implementation for the Future,” the summit brought together international experts in cardiology, oncology, and related disciplines to discuss recent scientific advances, emerging research, and clinical strategies for improving cardiovascular care in patients with cancer.
Jointly hosted by the VCU Health Pauley Heart Center, VCU Massey Comprehensive Cancer Center, and the International Cardio-Oncology Society (IC-OS), the meeting featured scientific sessions, expert discussions, and presentations addressing key developments in cardio-oncology.
Here are 20 posts not to miss from GCOS 2026, highlighting important scientific discussions, expert perspectives, and memorable moments from the meeting.
20 Posts Not To Miss From GCOS 2026
International Cardio-Oncology Society:
“GCOS26 is officially here!
Today’s program brings together global perspectives on cardio-oncology, along with plenty of time to connect with colleagues from across the field. Grab a coffee, take a look at the schedule, and join us at 8:00 AM sharp.
Full program: https://lnkd.in/eZqikSza”
“Michael Fradley, MD – President of International Cardio-Oncology Society opened the Global Cardio-Oncology Summit in Williamsburg”
“Patient Perspectives on the Cardio-Oncology Journey as the first session of Global Cardio-Oncology Summit in Williamsburg”
“GCOS 2026 — Opening Day in Williamsburg
OncoDaily is covering GCOS 2026 from historic Williamsburg, where leaders in cardio-oncology, survivorship, prevention, and innovation have gathered during this milestone year for our country’s 250th anniversary. The summit opened with a warm welcome from program leadership, acknowledging the clinicians, researchers, caregivers, and patients whose experiences continue to shape the field.
This year’s vision is clear: to move beyond the fundamentals of cardio-oncology and take a deeper look at the science, technology, and clinical strategies that can meaningfully improve outcomes for people living with and beyond cancer. The planning committee, community partners, and sponsors were recognized for bringing this symposium to life — a collaborative effort spanning academic centers, advocacy groups, and industry innovators.
GCOS 2026 begins with a patient-perspective session, grounding the next three days in the lived realities of those most affected by cancer and cardiovascular disease. As the meeting unfolds, we’ll highlight the conversations, discoveries, and practical insights that define the evolving landscape of cardio-oncology.”
“The Joint Session of ESC Council of Cardio-Oncology and International Cardio-Oncology Society led by Teresa López Fernández and Michael Fradley, MD at the Global Cardio-Oncology Summit in Williamsburg.”
“GCOS 2026 — Opening Reflections & The Promise of AI in Cardio-Oncology
GCOS 2026 opened with a message centered on gratitude, collaboration, and purpose. Leadership welcomed attendees to Williamsburg and emphasized how this year’s gathering reflects the strength of a community committed to advancing cardio-oncology. The opening remarks highlighted the collective effort behind the symposium — from planning teams and academic partners to community organizations and supporters who helped bring this meeting to life.
A central theme of the welcome was the recognition of patients, survivors, and caregivers whose experiences continue to shape the field. Their stories remain the driving force behind innovation, reminding us that every scientific advance must ultimately translate into better care, better outcomes, and better lives.
The vision for GCOS 2026 is clear: to move beyond foundational concepts and explore the cutting-edge science, technology, and clinical strategies that will define the next era of cardio-oncology. This includes a deeper look at how artificial intelligence can strengthen prediction, screening, workflow design, and clinical decision-making across the cancer-cardio continuum.
Today’s AI-focused session builds directly on that opening message. It examines how intelligent systems can help clinicians manage increasing complexity, support precision-based approaches, and redesign care pathways for a growing population of cancer survivors with cardiovascular needs.
OncoDaily is covering GCOS 2026 from Williamsburg, bringing forward the insights, discussions, and innovations shaping the future of cardio-oncology.”
“Looking forward to connecting with colleagues across cardiac care and ultrasound next week.
I’ll be attending both the International Cardio-Oncology Society’s #GCOS26 Summit and the IEEE IUS, Ultrasonics Symposium.
At #GCOS26, I’m particularly interested in the conversations around cardiac monitoring and cardiotoxicity surveillance. And at #IUS2026, I’m always excited to see what researchers and engineers across the ultrasound community have been working on.
If you’re going to be at either conference, send me a message. I’d love to connect.”
“Fantastic session highlighting the role AI can play in the field of Cardio-Oncology. International Cardio-Oncology Society, Avirup Guha, MD, MPH, MBA, FICOS, FACC, FAHA, FESC, Dinesh Thavendiranathan, Joerg Herrmann, Christine Brezden-Masley.”
“So great to connect with friends and colleagues at GCOS 2026. Great panel discussion on ICOS-ESC collaboration and how cardio-oncology has grown worldwide. I’m glad to share the Australian perspective and cardio-oncology journey. We hope to bring the Mobile Cardio-Oncology bus to implementation one day, servicing our regional, rural and remote population. Susan Dent, MD FRCPC, Michael Fradley, MD, Siva Tharshini Ramalingam, International Cardio-Oncology Society, Aaron Sverdlov.”
“We’re in Williamsburg, Virginia!
Instead of a lecture, the morning opened with three patients sitting on stage and talking about what it was really like to go through cancer and heart disease at the same time. No slides, just a conversation. What a refreshing take!! One man said he signed up for a clinical trial because people who look like him are so often missing from research, and he wanted to do his part for his community and for his grandsons. We usually talk about trial diversity as a number to hit. He talked about it as something he chose to take on. I’ll be bringing that back with me to how we think about recruitment.
After that, we heard from cardio-oncologists in Brazil, Japan, India and Australia about what they’re up against where they practice, and how ICOS could help us all work together better. The health systems are very different, but the problems sounded familiar: getting patients access, getting referrals right, and getting cardiology and oncology on the same page.
Good start. More to come.”
International Cardio-Oncology Society:
“GCOS is all about connecting and bringing the brightest minds in our field together.
Honored to have Cardio-Oncology titans Charles Porter, MD, Daniela Cardinale, and Joseph Carver with us today at GCOS 2026.”
International Cardio-Oncology Society:
“We’re excited to announce the winner of the 2026 Thomas Force Pioneer Award at GCOS26: Dr. Alexander Lyon!
If you’ve followed the growth of cardio-oncology over the past decade, Dr. Lyon’s name needs very little introduction. From chairing the flagship 2022 European Society of Cardiology Guidelines on Cardio-Oncology to building one of Europe’s leading Cardio-Oncology Centers of Excellence at Royal Brompton and Harefield hospitals, he has been at the forefront of transforming how we protect cancer patients’ hearts during treatment.
Congratulations, Dr. Lyon. Our field would not be what it is today without you.
Read the release: https://lnkd.in/epZUesxh”
“Huge congratulations to Alexander Lyon – the winner of the 2026 Thomas Force Pioneer Award at the Global Cardio-Oncology Summit in Williamsburg, Virginia, USA.”
“Deep learning, new insights, and the latest updates at GCOS 2026 with Morgan Smith, NP, Northside Hospital Heart Institute—bringing the latest in cardio-oncology back to our Northside program.
So nice to connect in person with Drs. Alexander Lyon, Sebastian Szmit, Sarju Ganatra, Daniel Lenihan, Avirup Guha, Stephen Casselli, Vijay Rao, and Michael Fradley, so many friends and colleagues from the International Cardio-Oncology Society (IC-OS).
Then & Now — Cardio-Oncology! From Toronto to Williamsburg—especially wonderful to reconnect with Dr. Alexander Lyon after seeing him in Toronto in 2020, and now also to see him receive the 2026 Thomas Force Award. Congratulations, Alex!
One message that continues to resonate: cardiovascular risk assessment, prevention, and cardiotoxicity monitoring should be an integral part of cancer care—from diagnosis and treatment through survivorship. We need to be mindful of the potential ‘double hit’ of cancer and cardiovascular disease. Our goal is not only successful cancer treatment, but helping our patients enter survivorship with the best cardiovascular health possible.”
“GCOS26 day 1 recap! From a wonderful joint European Society of Cardiology and International Cardio-Oncology Society session focusing on building Cardio-Oncology throughout the world, to sessions on AI and amyloidosis, the learning has been exceptional. We were touched by two tributes to trailblazers in the field we lost this past year and then honored a true giant in the field, Alexander Lyon, with the Thomas Force Award. We concluded with the inspiring young investigators competition, a gathering of the ICOS Next Gen, the future leaders of the organization and ended the night with the congress dinner, reconnecting with old friends and making new ones. What an incredible first day! Here’s to the beginning of a great day 2! Christine Brezden-Masley, Susan Dent, MD FRCPC, Teresa López Fernández.”
“Cardio-oncology is a true multidisciplinary research and patient care and I am excited that I had a poster presentation at GCOS 2026. Day 1 was very informative and great learning session. I hope next time we can active cardio-oncology Malaysia in future summits. International Cardio-Oncology Society Williamsburg 2026.”
International Cardio-Oncology Society:
“Many walks, one community.
So thankful to have our global community together in Virginia for GCOS 2026.”
Avirup Guha, MD, MPH, MBA, FICOS, FACC, FAHA, FESC:
“Session wrap: ‘The Future of Cardioprotection for Cancer Patients’ at GCOS 2026. Key themes: GLP-1 receptor agonists, risk-guided cardioprotection, statins, SGLT2 inhibitors & non-pharmacologic prevention of cardiotoxicity. Thanks to all the speakers! International Cardio-Oncology Society.”
“And that’s a wrap to the main event of GCOS26! Congratulations to Wendy Bottinor and Fadi N. Salloum for their hard work putting together a truly tremendous meeting! And thank you to the support of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center for their support! We will see you all in Tokyo for GCOS27. I know with the leadership Kazuhiro Sase, it will be an unforgettable experience! Book your flights now!”
GCOS 2026 First Half of the Day 1: Global Perspectives, AI and the Research Shaping Cardio-Oncology
